Suchergebnisse für: "faq"
Anzahl der Treffer in Dokumenten: [ 23 ]
2021-03-31 securPharm FAQ für pharmazeutische Unternehmenv4 – English
31 March 2021, Version 4 generated by securPharm e. V. 1 Questions and Answers about securPharm for Pharmaceutical Companies The FAQ collects questions addressed to securPharm e.V. by pharmaceutical companies or their service providers. The answers are not legally binding but represent the opinions and the state of knowledge of securPharm e.V. at the time they were generated. The term marketing authorisation holder (MAH) or pharmaceutical company describes a company ...
2021-03-31 securPharm FAQ für pharmazeutische Unternehmenv4
31 .03 .20 21, Version 4 erstellt von securPharm e. V. 1 Fragen und Antworten zu securPharm für pharmazeutische Unternehmen Die FAQs sammeln Fragen, die von pharmazeutischen Unternehmen bzw. von deren Dienstleistern an securPharm e. V. gerichtet wurden. Die Antworten haben keinen rechtsverbindlichen Charakter, sondern stellen die Auffassung und den Kenntnisstand von securPharm e. V. zum Datum der Erstellung dar. Pharmazeutische r Unternehme r oder pharmazeutisches Unternehme n bezeichnet de n Marketing authorisation holder (MAH), das ...
2020-09-02 securPharm FAQ für pharmazeutische UnternehmenV3 – englisch
2 September 2020, Version 3 generated by securPharm e. V. 1 Questions and Answers about securPharm for Pharmaceutical Companies The FAQ collects questions addressed to securPharm e.V. by pharmaceutical companies or their service providers. The answers are not legally binding but represent the opinions and the state of knowledge of securPharm e.V. at the time they were generated. Fo r questions regarding the implementation of the Falsified Medicines Directive and connection ...
Anzahl der Treffer in Beiträgen: [ 28 ]
Others
Zentrale Beschaffungsstellen nach §47 Nr 5 AMG (central purchasing entities) Access to the securPharm system via connection with the pharmacy system. Operating company is the NGDA – Netzgesellschaft deutscher Apotheker mbH. For questions regarding the technical connection, central purchasing entities or their software providers should contact NGDA or register at the partner portal of NGDA. NGDA is also responsible for the mandatory legtimcacy process. Under the menu item FAQ/Helpdesk, NGDA provides answers to questions regarding the N-Ident process. Industrielle Verblisterer ...
New FAQ (version 7) of the EU Commission
21.06.2017
The EU Commission has published in November 2017 its new FAQ document (version 7) to the Falsified Medicines Directive 2011/62/EU and the Delegated Regulation (EU) 2016/161.
New FAQ (version 8) of the EU Commission
23.11.2017
The EU Commission has published in November 2017 its new FAQ document (Version 8) to the Falsified Medicines Directive 2011/62/EU and the Delegated Regulation (EU) 2016/161.
